Fig. 1From: Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trialSchematic overview of the study design. In the non-randomized phase of the study, the same evaluations will be carried out, but all participants will receive the investigational productBack to article page